+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ramipril"

From
ACE Inhibitors Market Report 2025 - Product Thumbnail Image

ACE Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Lipid Regulators Market Report 2025 - Product Thumbnail Image

Lipid Regulators Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • March 2025
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 109 Pages
  • China
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Ramipril is a drug used to treat cardiovascular diseases, such as hypertension, congestive heart failure, and myocardial infarction. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. Ramipril is also used to reduce the risk of stroke, heart attack, and death in people with coronary artery disease. It is available in both generic and brand-name formulations. Ramipril is a widely used drug in the cardiovascular market, with a long history of safety and efficacy. It is generally well-tolerated and has few side effects. It is also cost-effective, making it an attractive option for many patients. Some of the companies in the Ramipril market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more